AIT Therapeutics Inc Share Price Nasdaq
Equities
US0014481099
Medical Equipment, Supplies & Distribution
Sales 2025 * | 9.67M 766M | Sales 2026 * | 31.61M 2.5B | Capitalization | 29.8M 2.36B |
---|---|---|---|---|---|
Net income 2025 * | -44M -3.48B | Net income 2026 * | -33M -2.61B | EV / Sales 2025 * | 3.39 x |
Net Debt 2025 * | 2.95M 234M | Net cash position 2026 * | - 0 | EV / Sales 2026 * | 0.94 x |
P/E ratio 2025 * |
-0.57
x | P/E ratio 2026 * |
-0.74
x | Employees | - |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 82.02% |
Latest transcript on AIT Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 12/01/17 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 31/08/21 |
Amir Avniel
PSD | President | 50 | 12/01/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 31/07/15 |
William Forbes
BRD | Director/Board Member | 62 | 12/08/18 |
Erick Lucera
BRD | Director/Board Member | 57 | 09/08/17 |
1st Jan change | Capi. | |
---|---|---|
-4.28% | 184B | |
-3.05% | 103B | |
-4.86% | 67.59B | |
+15.71% | 46.93B | |
-9.19% | 43.87B | |
+8.28% | 41.2B | |
+17.41% | 30.47B | |
+13.59% | 24.16B | |
-7.28% | 23.57B |